Invention Grant
- Patent Title: Histone demethylase inhibitors
-
Application No.: US14653818Application Date: 2013-12-19
-
Publication No.: US09617242B2Publication Date: 2017-04-11
- Inventor: Toufike Kanouni , Jeffrey Alan Stafford , James Marvin Veal , Michael Brennan Wallace
- Applicant: Quanticel Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: CELGENE QUANTICEL RESEARCH, INC.
- Current Assignee: CELGENE QUANTICEL RESEARCH, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wiley Rein LLP
- International Application: PCT/US2013/076666 WO 20131219
- International Announcement: WO2014/100463 WO 20140626
- Main IPC: C07D401/00
- IPC: C07D401/00 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D405/14 ; C07D413/12 ; C07D471/04 ; C07D413/14

Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted 3-aminopyridine derivative compounds, substituted 3-aminopyridazine derivative compounds, and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
Public/Granted literature
- US20160060247A1 HISTONE DEMETHYLASE INHIBITORS Public/Granted day:2016-03-03
Information query